Can Kushen injection combined with TACE improve therapeutic efficacy and safety in patients with advanced HCC? a systematic review and network meta-analysis.

导出 OA

翻译打印收藏纠错

作者： Yingshi,Zhang ^[1] ; Fuhai,Hui ^[1] ; Yue,Yang ^[1] ; Haixiao,Chu ^[1] ; Xiaochun,Qin ^[1] ; Mingyi,Zhao ^[1] ; Qingchun,Zhao ^[1]

作者单位： Department of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, P.R. China. ^[1] Department of Pharmacy, General Hospital of Shenyang Military Area Command, Shenyang 110840, P.R. China. ^[2]

关键词 TACE advanced hepatocellular carcinoma compound Kushen injection network meta-analysis transarterial chemoembolization

DOI 10.18632/oncotarget.20921

PMID 29291026

发布时间 2024-03-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览20

Oncotarget

2017年8卷63期

107258-107272页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Can Kushen injection combined with TACE improve therapeutic efficacy and safety in patients with advanced HCC? a systematic review and network meta-analysis.

Oncotarget

相似文献

Oncotarget

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Can Kushen injection combined with TACE improve therapeutic efficacy and safety in patients with advanced HCC? a systematic review and network meta-analysis.

Oncotarget

相似文献

Oncotarget

相关期刊

检索历史清除